-
1
-
-
45749116975
-
Rufinamide: Clinical pharmacokinetics and concentration-response relationships in patients with epilepsy
-
Perucca, E.; Cloyd, J.; Critchley, D.; Fuseau, E. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy. Epilepsia, 2008, 49(7), 1123-1141.
-
(2008)
Epilepsia
, vol.49
, Issue.7
, pp. 1123-1141
-
-
Perucca, E.1
Cloyd, J.2
Critchley, D.3
Fuseau, E.4
-
2
-
-
33745031316
-
Enzymes involved in the bioconversion of ester-based prodrugs
-
Liederer, B.M.; Borchardt, R.T. Enzymes involved in the bioconversion of ester-based prodrugs. J. Pharm. Sci., 2006, 95(6), 1177-1195.
-
(2006)
J. Pharm. Sci.
, vol.95
, Issue.6
, pp. 1177-1195
-
-
Liederer, B.M.1
Borchardt, R.T.2
-
3
-
-
77956232012
-
Genomic analysis of the carboxylesterases: Identification and classification of novel forms
-
Williams, E.T.; Wang, H.; Wrighton, S.A.; Qian, Y.W.; Perkins, E.J. Genomic analysis of the carboxylesterases: Identification and classification of novel forms. Mol. Phylogenet. Evol., 2010, 57(1), 23-34.
-
(2010)
Mol. Phylogenet. Evol.
, vol.57
, Issue.1
, pp. 23-34
-
-
Williams, E.T.1
Wang, H.2
Wrighton, S.A.3
Qian, Y.W.4
Perkins, E.J.5
-
4
-
-
53549084321
-
Structure and characterization of human carboxylesterase 1A1, 1A2, and 1A3 genes
-
Fukami, T.; Nakajima, M.; Maruichi, T.; Takahashi, S.; Takamiya, M.; Aoki, Y.; Mcleod, H.L.; Yokoi, T. Structure and characterization of human carboxylesterase 1A1, 1A2, and 1A3 genes. Pharmacogenet. Genomics, 2008, 18(10), 911-920.
-
(2008)
Pharmacogenet. Genomics.
, vol.18
, Issue.10
, pp. 911-920
-
-
Fukami, T.1
Nakajima, M.2
Maruichi, T.3
Takahashi, S.4
Takamiya, M.5
Aoki, Y.6
McLeod, H.L.7
Yokoi, T.8
-
5
-
-
14644422580
-
Mammalian carboxylesterases: From drug targets to protein therapeutics
-
Redinbo, M.R.; Potter, P.M. Mammalian carboxylesterases: from drug targets to protein therapeutics. Drug Discov. Today, 2005, 10(5), 313-325.
-
(2005)
Drug Discov. Today.
, vol.10
, Issue.5
, pp. 313-325
-
-
Redinbo, M.R.1
Potter, P.M.2
-
6
-
-
0036236051
-
Current progress on esterases: From molecular structure to function
-
Satoh, T.; Taylor, P.; Bosron, W.F.; Sanghani, S.P.; Hosokawa, M.; La Du, B.N. Current progress on esterases: from molecular structure to function. Drug Metab. Dispos., 2002, 30(5), 488-493.
-
(2002)
Drug Metab. Dispos.
, vol.30
, Issue.5
, pp. 488-493
-
-
Satoh, T.1
Taylor, P.2
Bosron, W.F.3
Sanghani, S.P.4
Hosokawa, M.5
la Du, B.N.6
-
7
-
-
69549137840
-
Human carboxylesterases: An update on CES1, CES2 and CES3
-
Sanghani, S.P.; Sanghani, P.C.; Schiel, M.A.; Bosron, W.F. Human carboxylesterases: an update on CES1, CES2 and CES3. Protein Pept. Lett., 2009, 16(10), 1207-1214.
-
(2009)
Protein Pept. Lett.
, vol.16
, Issue.10
, pp. 1207-1214
-
-
Sanghani, S.P.1
Sanghani, P.C.2
Schiel, M.A.3
Bosron, W.F.4
-
8
-
-
44449128538
-
Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: Clinical significance and molecular basis
-
Zhu, H.J.; Patrick, K.S.; Yuan, H.J.; Wang, J.S.; Donovan, J.L.; Devane, C.L.; Malcolm, R.; Johnson, J.A.; Youngblood, G.L.; Sweet, D.H.; Langaee, T.Y.; Markowitz, J.S. Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis. Am. J. Hum. Genet., 2008, 82(6), 1241-1248.
-
(2008)
Am. J. Hum. Genet.
, vol.82
, Issue.6
, pp. 1241-1248
-
-
Zhu, H.J.1
Patrick, K.S.2
Yuan, H.J.3
Wang, J.S.4
Donovan, J.L.5
Devane, C.L.6
Malcolm, R.7
Johnson, J.A.8
Youngblood, G.L.9
Sweet, D.H.10
Langaee, T.Y.11
Markowitz, J.S.12
-
9
-
-
34748886781
-
Haplotypes and a novel defective allele of CES2 found in a Japanese population
-
Kim, S.R.; Sai, K.; Tanaka-Kagawa, T.; Jinno, H.; Ozawa, S.; Kaniwa, N.; Saito, Y.; Akasawa, A.; Matsumoto, K.; Saito, H.; Kamatani, N.; Shirao, K.; Yamamoto, N.; Yoshida, T.; Minami, H.; Ohtsu, A.; Saijo, N.; Sawada, J. Haplotypes and a novel defective allele of CES2 found in a Japanese population. Drug Metab. Dispos., 2007, 35(10), 1865-1872.
-
(2007)
Drug Metab. Dispos.
, vol.35
, Issue.10
, pp. 1865-1872
-
-
Kim, S.R.1
Sai, K.2
Tanaka-Kagawa, T.3
Jinno, H.4
Ozawa, S.5
Kaniwa, N.6
Saito, Y.7
Akasawa, A.8
Matsumoto, K.9
Saito, H.10
Kamatani, N.11
Shirao, K.12
Yamamoto, N.13
Yoshida, T.14
Minami, H.15
Ohtsu, A.16
Saijo, N.17
Sawada, J.18
-
10
-
-
33747835599
-
Differences in absorption, distribution, metabolism and excretion of xenobiotics between the paediatric and adult populations
-
Strolin Benedetti, M.; Whomsley, R.; Baltes, E.L. Differences in absorption, distribution, metabolism and excretion of xenobiotics between the paediatric and adult populations. Expert Opin. Drug Metab. Toxicol., 2005, 1(3), 447-471.
-
(2005)
Expert Opin. Drug Metab. Toxicol.
, vol.1
, Issue.3
, pp. 447-471
-
-
Strolin, B.M.1
Whomsley, R.2
Baltes, E.L.3
-
11
-
-
57249113725
-
Human carboxylesterases HCE1 and HCE2: Ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin
-
Yang, D.; Pearce, R.E.; Wang, X.; Gaedigk, R.; Wan, Y.J.; Yan, B. Human carboxylesterases HCE1 and HCE2: ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin. Biochem. Pharmacol., 2009, 77(2), 238-247.
-
(2009)
Biochem. Pharmacol.
, vol.77
, Issue.2
, pp. 238-247
-
-
Yang, D.1
Pearce, R.E.2
Wang, X.3
Gaedigk, R.4
Wan, Y.J.5
Yan, B.6
-
12
-
-
79960581304
-
-
Wang, J.; Williams, E.T.; Bourgea, J.; Wong, Y.N.; Patten, C.J. Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2. Drug Metab. Dispos., 2011, 39(8), 1329-1333.
-
(2011)
Characterization of Recombinant Human Carboxylesterases: Fluorescein Diacetate as a Probe Substrate for Human Carboxylesterase 2
, vol.39
, Issue.8
, pp. 1329-1333
-
-
Wang, J.1
Williams, E.T.2
Bourgea, J.3
Wong, Y.N.4
Patten, C.J.5
-
13
-
-
40649095212
-
Effect of buffer components and carrier solvents on in vitro activity of recombinant human carboxylesterases
-
Williams, E.T.; Ehsani, M.E.; Wang, X.; Wang, H.; Qian, Y.W.; Wrighton, S.A.; Perkins, E.J. Effect of buffer components and carrier solvents on in vitro activity of recombinant human carboxylesterases. J. Pharmacol. Toxicol. Methods, 2008, 57(2), 138-144.
-
(2008)
J. Pharmacol. Toxicol. Methods.
, vol.57
, Issue.2
, pp. 138-144
-
-
Williams, E.T.1
Ehsani, M.E.2
Wang, X.3
Wang, H.4
Qian, Y.W.5
Wrighton, S.A.6
Perkins, E.J.7
-
14
-
-
0030965160
-
Purification and cloning of a broad substrate specificity human liver carboxylesterase that catalyzes the hydrolysis of cocaine and heroin
-
Pindel, E.V.; Kedishvili, N.Y.; Abraham, T.L.; Brzezinski, M.R.; Zhang, J.; Dean, R.A.; Bosron, W.F. Purification and cloning of a broad substrate specificity human liver carboxylesterase that catalyzes the hydrolysis of cocaine and heroin. J. Biol. Chem., 1997, 272(23), 14769-14775.
-
(1997)
J. Biol. Chem.
, vol.272
, Issue.23
, pp. 14769-14775
-
-
Pindel, E.V.1
Kedishvili, N.Y.2
Abraham, T.L.3
Brzezinski, M.R.4
Zhang, J.5
Dean, R.A.6
Bosron, W.F.7
-
15
-
-
19444380386
-
Hydrolysis of capecitabine to 5'-deoxy-5-fluorocytidine by human carboxylesterases and inhibition by loperamide
-
Quinney, S.K.; Sanghani, S.P.; Davis, W.I.; Hurley, T.D.; Sun, Z.; Murry, D.J.; Bosron, W.F. Hydrolysis of capecitabine to 5'-deoxy-5-fluorocytidine by human carboxylesterases and inhibition by loperamide. J. Pharmacol. Exp. Ther., 2005, 313(3), 1011-1016.
-
(2005)
J. Pharmacol. Exp. Ther.
, vol.313
, Issue.3
, pp. 1011-1016
-
-
Quinney, S.K.1
Sanghani, S.P.2
Davis, W.I.3
Hurley, T.D.4
Sun, Z.5
Murry, D.J.6
Bosron, W.F.7
-
16
-
-
33845996187
-
Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: Reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver
-
Barter, Z.E.; Bayliss, M.K.; Beaune, P.H.; Boobis, A.R.; Carlile, D.J.; Edwards, R.J.; Houston, J.B.; Lake, B.G.; Lipscomb, J.C.; Pelkonen, O.R.; Tucker, G.T.; Rostami-Hodjegan, A. Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver. Curr. Drug Metab., 2007, 8(1), 33-45.
-
(2007)
Curr. Drug Metab.
, vol.8
, Issue.1
, pp. 33-45
-
-
Barter, Z.E.1
Bayliss, M.K.2
Beaune, P.H.3
Boobis, A.R.4
Carlile, D.J.5
Edwards, R.J.6
Houston, J.B.7
Lake, B.G.8
Lipscomb, J.C.9
Pelkonen, O.R.10
Tucker, G.T.11
Rostami-Hodjegan, A.12
-
17
-
-
57349152452
-
Assessment of presystemic and systemic intestinal availability of orally administered drugs using in vitro and in vivo data in humans: Intestinal sulfation metabolism impacts presystemic availability much more than systemic availability of salbutamol, SULT1A3 substrate
-
Mizuma, T. Assessment of presystemic and systemic intestinal availability of orally administered drugs using in vitro and in vivo data in humans: intestinal sulfation metabolism impacts presystemic availability much more than systemic availability of salbutamol, SULT1A3 substrate. J. Pharm. Sci., 2008, 97(12), 5471-5476.
-
(2008)
J. Pharm. Sci.
, vol.97
, Issue.12
, pp. 5471-5476
-
-
Mizuma, T.1
-
18
-
-
34248654867
-
Hydrolysis of pyrethroids by human and rat tissues: Examination of intestinal, liver and serum carboxylesterases
-
Crow, J.A.; Borazjani, A.; Potter, P.M.; Ross, M.K. Hydrolysis of pyrethroids by human and rat tissues: examination of intestinal, liver and serum carboxylesterases. Toxicol. Appl. Pharmacol., 2007, 221(1), 1-12.
-
(2007)
Toxicol. Appl. Pharmacol.
, vol.221
, Issue.1
, pp. 1-12
-
-
Crow, J.A.1
Borazjani, A.2
Potter, P.M.3
Ross, M.K.4
-
19
-
-
0036023423
-
Human carboxylesterase 2 is commonly expressed in tumor tissue and is correlated with activation of irinotecan
-
Xu, G.; Zhang, W.; Ma, M.K.; Mcleod, H.L. Human carboxylesterase 2 is commonly expressed in tumor tissue and is correlated with activation of irinotecan. Clin. Cancer Res., 2002, 8(8), 2605-2611.
-
(2002)
Clin. Cancer Res.
, vol.8
, Issue.8
, pp. 2605-2611
-
-
Xu, G.1
Zhang, W.2
Ma, M.K.3
McLeod, H.L.4
-
20
-
-
0000996349
-
A new type of esterase in hogkidney extract
-
Bergmann, F.; Segal, R.; Rimon, S. A new type of esterase in hogkidney extract. Biochem. J., 1957, 67(3), 481-486.
-
(1957)
Biochem. J.
, vol.67
, Issue.3
, pp. 481-486
-
-
Bergmann, F.1
Segal, R.2
Rimon, S.3
-
21
-
-
58149469245
-
Effect of aging on glucuronidation of valproic acid in human liver microsomes and the role of UDPglucuronosyltransferase UGT1A4, UGT1A8, and UGT1A10
-
Argikar, U.A.; Remmel, R.P. Effect of aging on glucuronidation of valproic acid in human liver microsomes and the role of UDPglucuronosyltransferase UGT1A4, UGT1A8, and UGT1A10. Drug Metab. Dispos., 2009, 37(1), 229-236.
-
(2009)
Drug Metab. Dispos.
, vol.37
, Issue.1
, pp. 229-236
-
-
Argikar, U.A.1
Remmel, R.P.2
-
22
-
-
0842279426
-
Miscellaneous Reactions of Hydration and Dehydration
-
Verlag Helvetica Chimica Acta: Zürich, Switzerland
-
Testa, B.; Mayer, J.M., Miscellaneous Reactions of Hydration and Dehydration. In Hydrolysis in Drug and Prodrug Metabolism: Chemistry, Biochemistry, and Enzymology, Verlag Helvetica Chimica Acta: Zürich, Switzerland, 2003; pp 668-671.
-
(2003)
Hydrolysis in Drug and Prodrug Metabolism: Chemistry, Biochemistry, and Enzymology
, pp. 668-671
-
-
Testa, B.1
Mayer, J.M.2
-
23
-
-
0037422456
-
Acyl glucuronide reactivity in perspective: Biological consequences
-
Bailey, M.J.; Dickinson, R.G. Acyl glucuronide reactivity in perspective: biological consequences. Chem. Biol. Interact., 2003, 145(2), 117-137.
-
(2003)
Chem. Biol. Interact.
, vol.145
, Issue.2
, pp. 117-137
-
-
Bailey, M.J.1
Dickinson, R.G.2
-
24
-
-
0026724498
-
Metabolism of valproate to hepatotoxic intermediates
-
Baillie, T.A. Metabolism of valproate to hepatotoxic intermediates. Pharm. Weekbl. Sci., 1992, 14(3A), 122-125.
-
(1992)
Pharm. Weekbl. Sci.
, vol.14
, Issue.3 A
, pp. 122-125
-
-
Baillie, T.A.1
-
25
-
-
0015861774
-
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
-
Cheng, Y.; Prusoff, W.H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol., 1973, 22(23), 3099-3108.
-
(1973)
Biochem. Pharmacol.
, vol.22
, Issue.23
, pp. 3099-3108
-
-
Cheng, Y.1
Prusoff, W.H.2
-
26
-
-
67649411644
-
Human arylacetamide deacetylase is a principal enzyme in flutamide hydrolysis
-
Watanabe, A.; Fukami, T.; Nakajima, M.; Takamiya, M.; Aoki, Y.; Yokoi, T. Human arylacetamide deacetylase is a principal enzyme in flutamide hydrolysis. Drug Metab. Dispos., 2009, 37(7), 1513-1520.
-
(2009)
Drug Metab. Dispos.
, vol.37
, Issue.7
, pp. 1513-1520
-
-
Watanabe, A.1
Fukami, T.2
Nakajima, M.3
Takamiya, M.4
Aoki, Y.5
Yokoi, T.6
-
27
-
-
0029869127
-
Acylcoenzyme A:Cholesterol O-acyltransferase is not identical to liver microsomal carboxylesterase
-
Diczfalusy, M.A.; Bjorkhem, I.; Einarsson, K.; Alexson, S.E. Acylcoenzyme A:cholesterol O-acyltransferase is not identical to liver microsomal carboxylesterase. Arterioscler. Thromb. Vasc. Biol., 1996, 16(4), 606-610.
-
(1996)
Arterioscler. Thromb. Vasc. Biol.
, vol.16
, Issue.4
, pp. 606-610
-
-
Diczfalusy, M.A.1
Bjorkhem, I.2
Einarsson, K.3
Alexson, S.E.4
-
28
-
-
33947331734
-
Nafamostat is hydrolysed by human liver cytosolic long-chain acyl-CoA hydrolase
-
Yamaori, S.; Ukena, E.; Fujiyama, N.; Funahashi, T.; Kimura, T.; Yamamoto, I.; Ohshima, T.; Matsumura, K.; Oda, M.; Watanabe, K. Nafamostat is hydrolysed by human liver cytosolic long-chain acyl-CoA hydrolase. Xenobiotica, 2007, 37(3), 260-270.
-
(2007)
Xenobiotica
, vol.37
, Issue.3
, pp. 260-270
-
-
Yamaori, S.1
Ukena, E.2
Fujiyama, N.3
Funahashi, T.4
Kimura, T.5
Yamamoto, I.6
Ohshima, T.7
Matsumura, K.8
Oda, M.9
Watanabe, K.10
-
29
-
-
0036479293
-
The peroxisome proliferator-induced cytosolic type I acyl-CoA thioesterase (CTE-I) is a serine-histidine-aspartic acid alpha/beta hydrolase
-
Huhtinen, K.; O'byrne, J.; Lindquist, P.J.; Contreras, J.A.; Alexson, S.E. The peroxisome proliferator-induced cytosolic type I acyl-CoA thioesterase (CTE-I) is a serine-histidine-aspartic acid alpha/beta hydrolase. J. Biol. Chem., 2002, 277(5), 3424-3432.
-
(2002)
J. Biol. Chem.
, vol.277
, Issue.5
, pp. 3424-3432
-
-
Huhtinen, K.1
O'byrne, J.2
Lindquist, P.J.3
Contreras, J.A.4
Alexson, S.E.5
-
30
-
-
33744969383
-
Involvement of human blood arylesterases and liver microsomal carboxylesterases in nafamostat hydrolysis
-
Yamaori, S.; Fujiyama, N.; Kushihara, M.; Funahashi, T.; Kimura, T.; Yamamoto, I.; Sone, T.; Isobe, M.; Ohshima, T.; Matsumura, K.; Oda, M.; Watanabe, K. Involvement of human blood arylesterases and liver microsomal carboxylesterases in nafamostat hydrolysis. Drug Metab. Pharmacokinet., 2006, 21(2), 147-155.
-
(2006)
Drug Metab. Pharmacokinet.
, vol.21
, Issue.2
, pp. 147-155
-
-
Yamaori, S.1
Fujiyama, N.2
Kushihara, M.3
Funahashi, T.4
Kimura, T.5
Yamamoto, I.6
Sone, T.7
Isobe, M.8
Ohshima, T.9
Matsumura, K.10
Oda, M.11
Watanabe, K.12
-
31
-
-
34547671307
-
Specificity of procaine and ester hydrolysis by human, minipig, and rat skin and liver
-
Jewell, C.; Ackermann, C.; Payne, N.A.; Fate, G.; Voorman, R.; Williams, F.M. Specificity of procaine and ester hydrolysis by human, minipig, and rat skin and liver. Drug Metab. Dispos., 2007, 35(11), 2015-2022.
-
(2007)
Drug Metab. Dispos.
, vol.35
, Issue.11
, pp. 2015-2022
-
-
Jewell, C.1
Ackermann, C.2
Payne, N.A.3
Fate, G.4
Voorman, R.5
Williams, F.M.6
-
32
-
-
0036235529
-
Human and rodent carboxylesterases: Immunorelatedness, overlapping substrate specificity, differential sensitivity to serine enzyme inhibitors, and tumor-related expression
-
Xie, M.; Yang, D.; Liu, L.; Xue, B.; Yan, B. Human and rodent carboxylesterases: immunorelatedness, overlapping substrate specificity, differential sensitivity to serine enzyme inhibitors, and tumor-related expression. Drug Metab. Dispos., 2002, 30(5), 541-547.
-
(2002)
Drug Metab. Dispos.
, vol.30
, Issue.5
, pp. 541-547
-
-
Xie, M.1
Yang, D.2
Liu, L.3
Xue, B.4
Yan, B.5
-
33
-
-
9244225118
-
Ghrelin degradation by serum and tissue homogenates: Identification of the cleavage sites
-
De Vriese, C.; Gregoire, F.; Lema-Kisoka, R.; Waelbroeck, M.; Robberecht, P.; Delporte, C. Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites. Endocrinology, 2004, 145(11), 4997-5005.
-
(2004)
Endocrinology
, vol.145
, Issue.11
, pp. 4997-5005
-
-
de Vriese, C.1
Gregoire, F.2
Lema-Kisoka, R.3
Waelbroeck, M.4
Robberecht, P.5
Delporte, C.6
-
34
-
-
0030863434
-
Bioactivation of the anticancer agent CPT-11 to SN-38 by human hepatic microsomal carboxylesterases and the in vitro assessment of potential drug interactions
-
Slatter, J.G.; Su, P.; Sams, J.P.; Schaaf, L.J.; Wienkers, L.C. Bioactivation of the anticancer agent CPT-11 to SN-38 by human hepatic microsomal carboxylesterases and the in vitro assessment of potential drug interactions. Drug Metab. Dispos., 1997, 25(10), 1157-1164.
-
(1997)
Drug Metab. Dispos.
, vol.25
, Issue.10
, pp. 1157-1164
-
-
Slatter, J.G.1
Su, P.2
Sams, J.P.3
Schaaf, L.J.4
Wienkers, L.C.5
-
35
-
-
0031602129
-
Human liver paraoxonase (PON1): Subcellular distribution and characterization
-
Gonzalvo, M.C.; Gil, F.; Hernandez, A.F.; Rodrigo, L.; Villanueva, E.; Pla, A. Human liver paraoxonase (PON1): subcellular distribution and characterization. J. Biochem. Mol. Toxicol., 1998, 12(1), 61-69.
-
(1998)
J. Biochem. Mol. Toxicol.
, vol.12
, Issue.1
, pp. 61-69
-
-
Gonzalvo, M.C.1
Gil, F.2
Hernandez, A.F.3
Rodrigo, L.4
Villanueva, E.5
Pla, A.6
-
36
-
-
0031920093
-
Paraoxonase has a major role in the hydrolysis of prulifloxacin (NM441), a prodrug of a new antibacterial agent
-
Tougou, K.; Nakamura, A.; Watanabe, S.; Okuyama, Y.; Morino, A. Paraoxonase has a major role in the hydrolysis of prulifloxacin (NM441), a prodrug of a new antibacterial agent. Drug Metab. Dispos., 1998, 26(4), 355-359.
-
(1998)
Drug Metab. Dispos.
, vol.26
, Issue.4
, pp. 355-359
-
-
Tougou, K.1
Nakamura, A.2
Watanabe, S.3
Okuyama, Y.4
Morino, A.5
-
37
-
-
0029114527
-
Reconsideration of the catalytic center and mechanism of mammalian paraoxonase/arylesterase
-
Sorenson, R.C.; Primo-Parmo, S.L.; Kuo, C.L.; Adkins, S.; Lockridge, O.; La Du, B.N. Reconsideration of the catalytic center and mechanism of mammalian paraoxonase/arylesterase. Proc. Natl. Acad. Sci. U S A, 1995, 92(16), 7187-7191.
-
(1995)
Proc. Natl. Acad. Sci. U S A.
, vol.92
, Issue.16
, pp. 7187-7191
-
-
Sorenson, R.C.1
Primo-Parmo, S.L.2
Kuo, C.L.3
Adkins, S.4
Lockridge, O.5
la Du, B.N.6
-
38
-
-
18444379944
-
Analysis of active-site amino-acid residues of human serum paraoxonase using competitive substrates
-
Yeung, D.T.; Lenz, D.E.; Cerasoli, D.M. Analysis of active-site amino-acid residues of human serum paraoxonase using competitive substrates. FEBS. J., 2005, 272(9), 2225-2230.
-
(2005)
FEBS. J.
, vol.272
, Issue.9
, pp. 2225-2230
-
-
Yeung, D.T.1
Lenz, D.E.2
Cerasoli, D.M.3
-
39
-
-
0031214358
-
Inhibition of paraoxonase activity in human liver microsomes by exposure to EDTA, metals and mercurials
-
Gonzalvo, M.C.; Gil, F.; Hernandez, A.F.; Villanueva, E.; Pla, A. Inhibition of paraoxonase activity in human liver microsomes by exposure to EDTA, metals and mercurials. Chem. Biol. Interact., 1997, 105(3), 169-179.
-
(1997)
Chem. Biol. Interact.
, vol.105
, Issue.3
, pp. 169-179
-
-
Gonzalvo, M.C.1
Gil, F.2
Hernandez, A.F.3
Villanueva, E.4
Pla, A.5
-
40
-
-
0028883658
-
Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins
-
Abbott, C.A.; Mackness, M.I.; Kumar, S.; Boulton, A.J.; Durrington, P.N. Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. Arterioscler. Thromb. Vasc. Biol., 1995, 15(11), 1812-1818.
-
(1995)
Arterioscler. Thromb. Vasc. Biol.
, vol.15
, Issue.11
, pp. 1812-1818
-
-
Abbott, C.A.1
Mackness, M.I.2
Kumar, S.3
Boulton, A.J.4
Durrington, P.N.5
-
41
-
-
0042261695
-
Lactonase and lactonizing activities of human serum paraoxonase (PON1) and rabbit serum PON3
-
Teiber, J.F.; Draganov, D.I.; La Du, B.N. Lactonase and lactonizing activities of human serum paraoxonase (PON1) and rabbit serum PON3. Biochem. Pharmacol., 2003, 66(6), 887-896.
-
(2003)
Biochem. Pharmacol.
, vol.66
, Issue.6
, pp. 887-896
-
-
Teiber, J.F.1
Draganov, D.I.2
la Du, B.N.3
|